Fancy bioisosteres: synthesis and dopaminergic properties of the endiyne FAUC 88 as a novel non-aromatic D3 agonist.
暂无分享,去创建一个
Harald Hübner | Peter Gmeiner | F. Boeckler | P. Gmeiner | H. Hübner | C. Haubmann | Frank Boeckler | Carola Lenz | Christian Haubmann | C. Lenz
[2] M. J. Heeg,et al. Total Synthesis of (±)-Tazettine , 1998 .
[3] M. Martres,et al. Pharmacology of human dopamine D3 receptor expressed in a mammalian cell line: comparison with D2 receptor. , 1992, European journal of pharmacology.
[4] P. Gmeiner,et al. 2,2-Dicyanovinyl as a nonaromatic aryl bioisostere: synthesis, binding experiments and SAR studies of highly selective dopamine D4 receptor ligands. , 1999, Bioorganic & medicinal chemistry letters.
[5] Harald Hübner,et al. Interactive SAR studies: rational discovery of super-potent and highly selective dopamine D3 receptor antagonists and partial agonists. , 2002, Journal of medicinal chemistry.
[6] F. Diederich,et al. Interactions with aromatic rings in chemical and biological recognition. , 2003, Angewandte Chemie.
[7] P. Gmeiner,et al. Effective and Variable Functionalization of Pyrazolo[1,5-a]pyridines Involving Palladium-Catalyzed Coupling Reactions , 2000 .
[8] Y. Cheng,et al. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. , 1973, Biochemical pharmacology.
[9] Harald Hübner,et al. Analogues of FAUC 73 revealing new insights into the structural requirements of nonaromatic dopamine D3 receptor agonists. , 2004, Bioorganic & medicinal chemistry.
[10] T. Biden,et al. Structural subtypes of the dopamine D2 receptor are functionally distinct: expression of the cloned D2A and D2B subtypes in a heterologous cell line. , 1992, Molecular Endocrinology.
[11] N. Krause,et al. Improved Procedures for the Palladium-Catalyzed Coupling of Terminal Alkynes with Aryl Bromides (Sonogashira Coupling)† , 1998 .
[12] P. Gmeiner,et al. Planar chiral indoles: synthesis and biological effects of the enantiomers , 2001 .
[13] A. Wettstein. Fortschritte der Arzneimittelforschung , 1960, Experientia.
[14] P. Gmeiner,et al. Cyanoindole derivatives as highly selective dopamine D(4) receptor partial agonists: solid-phase synthesis, binding assays, and functional experiments. , 2000, Journal of medicinal chemistry.
[15] P. Gmeiner,et al. Ex-chiral pool synthesis and receptor binding studies of 4-substituted prolinol derivatives , 2003 .
[16] H. V. Van Tol,et al. Modulation of Intracellular Cyclic AMP Levels by Different Human Dopamine D4 Receptor Variants , 1995, Journal of neurochemistry.
[17] G. Ortar,et al. Palladium-Catalyzed Reaction of Enol Triflates with 1-Alkynes. A New Route to Conjugated Enynes , 1986 .
[18] K. Rosauer,et al. The Twofold Heck Reaction on 1,2‐Dihalocycloalkenes and Subsequent 6π‐Electrocyclization of the Resulting (E, Z, E)‐1,3,5‐Hexatrienes: A New Formal {2+2+2}‐Assembly of Six‐Membered Rings , 1998 .
[19] P. Gmeiner,et al. Conjugated enynes as nonaromatic catechol bioisosteres: synthesis, binding experiments, and computational studies of novel dopamine receptor agonists recognizing preferentially the D(3) subtype. , 2000, Journal of medicinal chemistry.
[20] K. Rühlmann. Die Umsetzung von Carbonsäureestern mit Natrium in Gegenwart von Trimethylchlorsilan , 1971 .
[21] P. Gmeiner,et al. Indoloparacyclophanes: Synthesis and Dopamine Receptor Binding of a Novel Arylbioisostere This work was supported by the Fonds der Chemischen Industrie. , 2001, Angewandte Chemie.